As of 5 Jul 2026, DR AGARWALS HEALTH CARE L share price is ₹476.45. The stock opened at ₹479.00, compared to its previous close of ₹476.60. During today's trading session, DR AGARWALS HEALTH CARE L share price moved in the range of ₹471.55 to ₹481.85, with an average price of ₹476.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹401.00 and a high of ₹568.00. On the performance front, DR AGARWALS HEALTH CARE L share price has declined by 4.85% over the last six months and is up 15.99% on a year-on-year basis.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,711.00 | ₹1,332.15 | ₹1,017.98 | ₹696.08 |
| Other Income | ₹46.02 | ₹44.30 | ₹13.51 | ₹17.71 |
| Total Revenue | ₹1,757.02 | ₹1,376.45 | ₹1,031.49 | ₹713.78 |
| Total Expenses | ₹1,594.15 | ₹1,235.88 | ₹947.90 | ₹657.02 |
| Profit Before Tax | ₹159.85 | ₹140.57 | ₹83.59 | ₹56.76 |
| Tax | ₹49.51 | ₹45.52 | -₹19.64 | ₹13.60 |
| Profit After Tax | ₹110.34 | ₹95.05 | ₹103.23 | ₹43.16 |
| EPS - Basic | ₹2.80 | ₹3.14 | ₹4.01 | ₹1.83 |
| EPS - Diluted | ₹2.78 | ₹3.13 | ₹4.00 | ₹1.83 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹159.85 | ₹140.57 | ₹83.59 | ₹56.76 |
| Income before WC changes | ₹491.35 | ₹373.44 | ₹280.99 | ₹194.94 |
| Change in Assets | -₹129.78 | -₹47.83 | -₹31.12 | -₹37.12 |
| Change in Liabilities | ₹35.36 | ₹52.47 | ₹18.61 | ₹22.11 |
| Change in WC | -₹94.42 | ₹4.64 | -₹12.51 | -₹15.01 |
| Cash flow from Operations | ₹360.33 | ₹346.00 | ₹233.11 | ₹164.33 |
| Cash flow from Investing | -₹750.33 | -₹913.91 | -₹509.09 | -₹155.35 |
| Cash flow from Financing | ₹381.86 | ₹552.68 | ₹303.34 | ₹35.43 |
| Total Cash Flow | -₹8.14 | -₹15.23 | ₹27.36 | ₹44.41 |
| Cash (Start of the year) | ₹111.75 | ₹126.98 | ₹99.62 | ₹55.21 |
| Cash (End of the year) | ₹103.61 | ₹111.75 | ₹126.98 | ₹99.62 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2,877.50 | ₹1,994.24 | ₹1,515.00 | ₹798.65 |
| Current Assets | ₹794.07 | ₹758.58 | ₹310.18 | ₹227.48 |
| Total Assets | ₹3,671.57 | ₹2,752.82 | ₹1,825.17 | ₹1,026.13 |
| Current Liabilities | ₹477.76 | ₹399.80 | ₹301.32 | ₹206.00 |
| Net Current Asset | ₹316.31 | ₹358.78 | ₹8.86 | ₹21.48 |
| Non-Current Liabilities | ₹1,266.99 | ₹973.51 | ₹864.79 | ₹586.31 |
| Equity Capital | ₹1,926.82 | ₹1,379.51 | ₹659.07 | ₹233.82 |
| Total Equity & Liabilities | ₹3,671.57 | ₹2,752.82 | ₹1,825.17 | ₹1,026.13 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,043.89 | ₹835.06 | ₹597.64 | ₹361.59 |
| Other Income | ₹53.81 | ₹47.28 | ₹17.70 | ₹10.37 |
| Total Revenue | ₹1,097.70 | ₹882.34 | ₹615.34 | ₹371.96 |
| Total Expenses | ₹1,045.10 | ₹828.39 | ₹591.98 | ₹372.91 |
| Profit Before Tax | ₹38.60 | ₹44.66 | -₹5.84 | -₹0.95 |
| Tax | ₹16.67 | ₹20.83 | -₹37.43 | ₹0.52 |
| Profit After Tax | ₹21.93 | ₹23.83 | ₹31.59 | -₹1.47 |
| EPS - Basic | ₹0.74 | ₹0.90 | ₹1.34 | -₹2.15 |
| EPS - Diluted | ₹0.73 | ₹0.90 | ₹1.34 | -₹2.15 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹38.60 | ₹44.66 | -₹5.84 | -₹0.95 |
| Income before WC changes | ₹265.83 | ₹232.86 | ₹168.81 | ₹96.14 |
| Change in Assets | -₹88.17 | -₹32.64 | -₹12.84 | -₹27.67 |
| Change in Liabilities | ₹24.00 | ₹34.33 | ₹9.00 | ₹17.73 |
| Change in WC | -₹64.17 | ₹1.69 | -₹3.84 | -₹9.94 |
| Cash flow from Operations | ₹208.00 | ₹221.58 | ₹152.69 | ₹78.30 |
| Cash flow from Investing | -₹577.46 | -₹817.60 | -₹435.57 | -₹98.43 |
| Cash flow from Financing | ₹374.08 | ₹570.41 | ₹315.94 | ₹40.16 |
| Total Cash Flow | ₹4.62 | -₹25.61 | ₹33.06 | ₹20.03 |
| Cash (Start of the year) | ₹51.20 | ₹76.81 | ₹43.75 | ₹23.71 |
| Cash (End of the year) | ₹55.82 | ₹51.20 | ₹76.81 | ₹43.74 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2,205.86 | ₹1,556.71 | ₹1,186.91 | ₹569.55 |
| Current Assets | ₹630.91 | ₹630.23 | ₹200.67 | ₹122.90 |
| Total Assets | ₹2,836.77 | ₹2,186.94 | ₹1,387.58 | ₹692.45 |
| Current Liabilities | ₹341.84 | ₹276.94 | ₹213.30 | ₹116.31 |
| Net Current Asset | ₹289.07 | ₹353.29 | -₹12.63 | ₹6.59 |
| Non-Current Liabilities | ₹561.29 | ₹682.79 | ₹612.72 | ₹377.23 |
| Equity Capital | ₹1,933.64 | ₹1,227.21 | ₹561.56 | ₹198.91 |
| Total Equity & Liabilities | ₹2,836.77 | ₹2,186.94 | ₹1,387.58 | ₹692.45 |
Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The Company is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. It provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. It provides a range of glasses, lenses, contact lenses and frames at its facilities.
DR AGARWALS HEALTH CARE L share price is ₹476.45 as on 03 Jul, 2026, 15:29 IST.
In the last 1 year, DR AGARWALS HEALTH CARE L delivered a return of 15.99%. The DR AGARWALS HEALTH CARE L share price hit a high of ₹568.00 and low of ₹401.00.
The Mutual Fund Shareholding in DR AGARWALS HEALTH CARE L was 5.87% at the end of Mar 2026.
The 52-week high and low of DR AGARWALS HEALTH CARE L share is ₹568.00 and ₹401.00 as of 03 Jul, 2026.
The market capitalisation of DR AGARWALS HEALTH CARE L is ₹15,099.50 Crores as on 03 Jul, 2026.
The stock symbol of DR AGARWALS HEALTH CARE L is AGARWALEYE on the NSE, 544350 on the BSE, and the ISIN is INE943P01029.
DR AGARWALS HEALTH CARE L shares closed yesterday at ₹476.60 on NSE & ₹476.35 on BSE
To buy DR AGARWALS HEALTH CARE L shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of DR AGARWALS HEALTH CARE L or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell DR AGARWALS HEALTH CARE L shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of DR AGARWALS HEALTH CARE L is 89.88 and 7.45 respectively, as on 03 Jul, 2026, 15:29 IST.